樂途達錠80毫克 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

樂途達錠80毫克

台灣住友醫藥股份有限公司 臺北市大同區南京西路62號15樓之2及15樓之3 (83155280) - lurasidone hcl - 膜衣錠 - lurasidone hcl (2816402610) mg - lurasidone - 1、思覺失調症:用於治療成人和青少年(13至17歲)的思覺失調症。2、第一型雙極性疾患之鬱症發作:單一療法用於治療患有第一型雙極性疾患之鬱症發作的成人和兒童及青少年(10至17歲)病人。配合鋰鹽或valproate之輔助療法用於治療患有第一型雙極性疾患之鬱症發作的成人病人。

克癌平 凍晶注射劑150毫克 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

克癌平 凍晶注射劑150毫克

台灣羅氏醫療診斷設備股份有限公司 台北市中山區民權東路3段2號10樓 (23932173) - trastuzumab - 凍晶注射劑 - trastuzumab (1013000500) mg - trastuzumab - herclon應使用於下列her2過度表現或her2基因amplification之早期乳癌、轉移性乳癌患者說明:1.早期乳癌(ebc):(1)經外科手術、化學療法(術前或術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,再合併pactlitaxel或docetaxel之輔助療法。(3)與docetaxel及carboplatin併用之輔助療法。(4)術前與化學療法並用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(mbc):(1)單獨使用於曾接受過一次(含)以上化學療法之轉移性乳癌;除非患者不適合使用anthracyclin或taxane,否則先前之化學治療應至少包括anthracyclin或taxane。使用於荷爾蒙療法失敗之荷爾蒙受體陽性之患者,除非患者不適用荷爾蒙療法。(2)與pactlitaxel或docetaxel併用於未曾接受過化學療法之轉移性乳癌。(3)與芳香環酶抑制劑併用於荷爾蒙受體陽性之轉移性乳癌。3.轉移性胃癌(mgc):herceptin合併capecitabine(或5-f1uorouracil)及cisplatin適用於未曾接受過化學治療之her2過度表現轉移性胃腺癌(或胃食道接合處腺癌)的治療。

"愛瑞"人類血清白蛋白20%注射液 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"愛瑞"人類血清白蛋白20%注射液

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - human albumin - 注射液劑 - human albumin (1600000150) (human plasma protein with at least 96% albumin)g/l - albumin - 低蛋白血症、休克、燒傷。

"愛瑞"人類血清白蛋白25%注射液 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"愛瑞"人類血清白蛋白25%注射液

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - human albumin - 注射液劑 - human albumin (1600000150) (human plasma protein with at least 95% albumin)g/l - albumin - 低蛋白血症、休克、燒傷。

欣保康力靜脈營養輸注液 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

欣保康力靜脈營養輸注液

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - sodium chloride;;phenylalanine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;serine;;magnesium acetate tetrahydrate;;calcium chloride dihydrate;;glycine (eq to aminoacetic acid)(eq to glycocoll);;valine;;methionine;;threonine;;isoleucine;;sodium hydroxide;;alanine;;tryptophan;;proline;;potassium hydroxide;;glutamic acid;;histidine hcl monohydrate;;aspartic acid;;glucose (monohydrate);;leucine;;potassium dihydrogen phosphate;;lysine hcl;;arginine monoglutamate l- - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 1.56gm; calcium chloride dihydrate (4012000350) 0.37gm; magnesium acetate tetrahydrate (4012001450) 0.86gm; sodium chloride (4012002100) 0.17gm; glucose (monohydrate) (4020009760) 88.00gm; alanine (4020100200) 4.85gm; arginine monoglutamate l- (4020100342) 4.98gm; aspartic acid (4020100400) 1.50gm; glutamic acid (4020100700) 1.22gm; histidine hcl monohydrate (4020100915) 1.69gm; isoleucine (4020101000) 2.34gm; leucine (4020101200) 3.13gm; lysine hcl (4020101310) 2.84gm; methionine (4020101500) 1.96gm; phenylalanine (4020101700) 3.51gm; proline (4020101800) 3.40gm; serine (4020101900) 3.00gm; threonine (4020102000) 1.82gm; tryptophan (4020102100) 0.57gm; valine (4020102300) 2.60gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 1.65gm; potassium dihydrogen phosphate (5612001920) 0.78gm; potassium hydroxide (9600024100) gm; sodium hydroxide (9600028200) 0.50gm - combinations - 無法經口服攝食或腸道吸收營養、功能不全或有禁忌症時,對輕微到中等異化作用狀態的病人的靜脈營養提供氨基酸、葡萄糖、電解質和液體。欣保康力靜脈營養輸注液適用於成人和2 到17 歲的兒童。

"費森尤斯"腹膜透析液 19 號 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"費森尤斯"腹膜透析液 19 號

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - sodium chloride;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;calcium chloride dihydrate;;glucose monohydrate;;sodium lactate solution - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; glucose monohydrate (4020000760) gm - peritoneal dialytics - 腹膜透析。

"費森尤斯"腹膜透析液 17 號 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"費森尤斯"腹膜透析液 17 號

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;calcium chloride dihydrate;;sodium lactate solution;;glucose monohydrate;;sodium chloride - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; glucose monohydrate (4020000760) gm - peritoneal dialytics - 腹膜透析。

"費森尤斯"腹膜透析液 18 號 Đài Loan - Tiếng Trung - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"費森尤斯"腹膜透析液 18 號

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;sodium lactate solution;;sodium chloride;;glucose monohydrate - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; glucose monohydrate (4020000760) gm - peritoneal dialytics - 腹膜透析。